News – Page 911 – Endpoints News

SIGN UP

AveXis scientific founder was axed — and Novartis names a new CSO in wake of an ethics scandal

6 years ago

Senators accuse Teva, Mylan of stonewalling price fixing probe; Myriad Genetics shares skid on dismal quarterly ...

6 years ago

Armed with stellar — if niche — PhIII data, Regeneron steers 'breakthrough' cholesterol drug to post-PCSK9 waters

6 years ago

Johns Hopkins scientists raise $137M megaround for a trio of spinouts looking to tackle Alzheimer’s, Parkinson’s ...

6 years ago

As investors fret about Xyrem durability, Jazz spends $52M+ upfront to swallow neuro-focused biotech

6 years ago

As disaster struck, AbbVie’s Rick Gonzalez swooped in on Allergan with an offer Brent Saunders couldn’t say no to

6 years ago

Eli Lilly's Taltz beats J&J's Tremfya in psoriasis head-to-head — but the marketing brawl is just beginning

6 years ago

Biotech targeting rare heart mutation with gene therapy scores $11M in Series A haul

6 years ago

AstraZeneca's juggernaut PARP player Lynparza scoops up another dominant win in PhIII as the FDA adds a ...

6 years ago

Plugging in the last piece to its gene therapy puzzle, AskBio acquires Scottish synthetic promoter company

6 years ago

Regeneron's pre-filled Eylea syringe makes the FDA cut; CureVac inks pact with Yale

6 years ago

Novartis offloads a late-stage PI3Kẟ rare disease program in a discount deal

6 years ago

As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs

6 years ago

Powerful Republican Chuck Grassley attacks Novartis CEO Narasimhan for ‘reprehensible’ decision to hide data

6 years ago

Trump's key drug pricing advisor O'Brien makes HHS exit

6 years ago

Little Deciphera will hustle positive PhIII survival data on lead cancer drug to the FDA in search of its first OK ...

6 years ago

IBD startup Landos lands $60M Series B in first test case of Chris Garabedian's lean and mean model at Xontogeny

6 years ago

Questions pile up for Novartis as senators call on FDA to take action

6 years ago

Make that 2 new US Big Pharma chiefs today, as Novartis remakes top team

6 years ago

How does TDP-43 bog up the brains of ALS, FTLD patients? AC Immune enlists Penn scientists to find out

6 years ago

Ebola trial stopped early as Regeneron, Ridgeback therapies cut death risk; Merck inks deal to test Keytruda with ...

6 years ago

Shifting focus to oncology, GSK recruits a cancer vet as new chief of US pharmaceuticals — adding another woman to ...

6 years ago

Boehringer follows the popular KRAS trail to MD Anderson — inks new alliance on 'virtual' research center

6 years ago

Key Apple digital health researcher set to join the Gates Foundation — report

6 years ago

First page Previous page 908 909 910911912 913 914 Next page Last page